RHUMBLINE ADVISERS - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 59 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$299,126
-16.5%
54,887
+4.0%
0.00%
Q2 2023$358,437
+146800.4%
52,789
+8.5%
0.00%
Q1 2023$244
+2.5%
48,634
-0.2%
0.00%
Q4 2022$238
-100.0%
48,749
+4.2%
0.00%
-100.0%
Q3 2022$675,000
+2.6%
46,805
+7.6%
0.00%0.0%
Q2 2022$658,000
+53.4%
43,511
+20.6%
0.00%0.0%
Q1 2022$429,000
-27.3%
36,092
-0.9%
0.00%0.0%
Q4 2021$590,000
-44.2%
36,417
-1.6%
0.00%0.0%
Q3 2021$1,057,000
-10.7%
37,022
+5.7%
0.00%
-50.0%
Q2 2021$1,184,000
+9.7%
35,021
-1.9%
0.00%
+100.0%
Q1 2021$1,079,000
-43.4%
35,696
-7.3%
0.00%
-66.7%
Q4 2020$1,906,000
+35.9%
38,496
+5.3%
0.00%
+50.0%
Q3 2020$1,403,000
-22.4%
36,555
-12.7%
0.00%
-33.3%
Q2 2020$1,809,000
+147.1%
41,875
+49.3%
0.00%
+50.0%
Q1 2020$732,000
-14.0%
28,048
+3.0%
0.00%
+100.0%
Q4 2019$851,000
+48.0%
27,222
+23.4%
0.00%0.0%
Q3 2019$575,000
+17.3%
22,053
+2.9%
0.00%0.0%
Q2 2019$490,00021,4370.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 2,104,278$54,837,0004.96%
Cormorant Asset Management, LP 883,800$23,032,0001.40%
SPHERA FUNDS MANAGEMENT LTD. 190,000$4,951,0000.76%
Perceptive Advisors 854,940$22,280,0000.60%
Artal Group S.A. 400,000$10,424,0000.42%
DRIEHAUS CAPITAL MANAGEMENT LLC 207,089$5,397,0000.18%
Vident Investment Advisory, LLC 64,571$1,683,0000.15%
Tuttle Capital Management, LLC 11,618$309,0000.08%
Baker Brothers Advisors 102,800$2,679,0000.02%
AXA S.A. 311,010$8,104,0000.02%
View complete list of Y-MABS THERAPEUTICS INC shareholders